FTI Consulting Inc reports significant year-over-year growth in revenue and earnings, alongside strategic discussions on market conditions and corporate developments.
Robust quarterly growth with reaffirmed guidance, significant share repurchases, and detailed executive insights on future strategies.
Despite a dip in Q1 performance, West Pharmaceutical projects a robust year with strategic expansions and improved guidance.